Inhibition of SN-38 glucuronidation by gefitinib and its metabolite

Release Time:2022-10-06  Hits:

Date of Publication: 2022-10-03

Journal: CANCER CHEMOTHERAPY AND PHARMACOLOGY

Volume: 75

Issue: 6

Page Number: 1253-1260

ISSN: 0344-5704

Prev One:Induction of CYP1A1 increases gefitinib-induced oxidative stress and apoptosis in A549 cells

Next One:HMGA2 plays an important role in Cr (VI)-induced autophagy